SMI 3Fourteen REAL Asset Allocation ETF (RAA)
Live price chart, market sentiment, and community perspectives for SMI 3Fourteen REAL Asset Allocation ETF (NASDAQ: RAA).
Live price chart, market sentiment, and community perspectives for SMI 3Fourteen REAL Asset Allocation ETF (NASDAQ: RAA).
On our trading desk, we've been monitoring the flow on the SMI 3Fourteen REAL Asset Allocation ETF (RAA). With short interest sitting down at just 3,100 shares—representing a minuscule 0.02% of the public float as of late July 2026—there is virtually no bearish conviction or institutional hedging against it at the moment. Trading around $29.43 to $30.33, the market sentiment feels neutral to cautiously steady. While it lacks the explosive liquidity of major tech ETFs, its clear focus on commodities and real estate gives allocators a straightforward mechanism to target real assets without facing structural short pressure.
Looking at the quantitative profile of the SMI 3Fourteen REAL Asset Allocation ETF (RAA), the lack of short interest is striking. When only 0.02% of the public float is sold short, it tells me that short-sellers are completely ignoring the ticker, likely due to its specific asset mix focusing on commodities and real estate. However, low short interest doesn't automatically equal explosive upside; it often points to a quiet holding pattern. From a risk-adjusted perspective, comparing it against peers like Alpha Architect High Inflation And or looking at its performance metrics via PortfoliosLab will be essential before scaling into any significant position.
When evaluating real asset strategies like the SMI 3Fourteen REAL Asset Allocation ETF (RAA) for portfolio inclusion, analysts need to look closely under the hood at its underlying commodity and real estate weightings. Given that the fund trades on Nasdaq under the ticker RAA and maintains a tight price band near the $29-$30 handle, my technical protocol involves tracking its bid-ask spread and daily volume consistency. Because public data highlights very minimal short interest (0.02%), analysts shouldn't expect a short squeeze catalyst here; performance will depend entirely on the fundamental tailwinds of the underlying real estate and commodity holdings.
Explore plasma cleansing, somatic organ swaps, and BCI.